National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Non-Hodgkin Lymphoma
Demographics (2)
- Days to birth - Number of days to birth (phv00173802.v2.p6)
- Gender - Gender (phv00173803.v2.p6)
Disease Events (17)
- Cause of death - Cause of death (phv00173823.v2.p6)
- Cause of death ICD10 - Cause of death ICD10 (phv00173824.v2.p6)
- Extranodal sites - Sites of extranodal disease (phv00173808.v2.p6)
- HSCT (yes/no) - Hematopoietic stem cell transplant (HSCT) (phv00173818.v2.p6)
- IPI score - International prognostic index (IPI) score (phv00173810.v2.p6)
- LDH_RATIO - Lactate dehydrogenase level (LDH) as ratio of measured value/upper limit of normal (phv00173807.v2.p6)
- Percent Tumor - Percent tumor (phv00173831.v2.p6)
- Performance status - Performance status (ECOG) (phv00173806.v2.p6)
- Primary treatment - Primary treatment (phv00173811.v2.p6)
- Response - Response to primary treatment (phv00173813.v2.p6)
- Secondary treatment - Secondary treatment (phv00173817.v2.p6)
- Site progression - Primary site of progression (phv00173816.v2.p6)
- Stage - Stage (Ann Arbor) (phv00173804.v2.p6)
- Stage group - Stage (limited vs advanced) (phv00173805.v2.p6)
- Status last follow-up (alive/dead) - Status at last follow-up (phv00173822.v2.p6)
- Tumor size - Largest tumor mass diameter (phv00173809.v2.p6)
- WHO diagnosis - WHO diagnosis (phv00173801.v2.p6)
Other (14)
- ANALYTETYPE - Analyte (phv00173826.v2.p6)
- Days to HSCT - Number of days to HSCT (phv00173819.v2.p6)
- Days to last follow-up - Number of days to last follow-up (phv00173821.v2.p6)
- Days to Primary treatment start - Number of days to primary treatment start (phv00173812.v2.p6)
- Days to progression - Number of days to progressive disease, if occurred (phv00173815.v2.p6)
- Days to response assessment - Number of days to response assessment (phv00173814.v2.p6)
- Days to transformed lymphoma diagnosed - Number of days to date transformed lymphoma diagnosed (phv00173820.v2.p6)
- DISEASEPROJECT - Disease project (phv00259022.v1.p6)
- LIBRARYTYPE - Library Type (phv00173827.v2.p6)
- SAMPLENAME - Sample Id (phv00173825.v2.p6)
- SUBJID - CGCI Subject Id (phv00173800.v2.p6)
- TISSUE - Tissue site (phv00173829.v2.p6)
- TISSUESTATUS - Tissue status (phv00173830.v2.p6)
- Treatment status at sample acquisition - Treatment status at sample acquisition (phv00173828.v2.p6)